BETRF (BetterLife Pharma) Tax Provision: $0.00 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BETRF BetterLife Pharma Inc BETRF
29 GF Score
Price $0.14
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma Tax Provision?

BetterLife Pharma BETRF +3.79% 29 Tax Provision is $0.00 Mil as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

BetterLife Pharma's tax provision for the three months ended in Apr. 2026 was $0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Apr. 2026 was $0.00 Mil.

BetterLife Pharma Tax Provision Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Tax Provision Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 0.00 0.00 0.00 0.00

BetterLife Pharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BETRF
29GF Score
BetterLife Pharma Inc BETRF
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of $0.00 Mil mean?
BetterLife Pharma (BETRF) has a Tax Provision of $0.00 Mil as of Apr. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's Tax Provision too high?
BetterLife Pharma's current Tax Provision is $0.00 Mil. Overall, BetterLife Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Tax Provision compare to VRTX and REGN?
BetterLife Pharma's Tax Provision of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Biotechnology company?
A good Tax Provision depends on the Biotechnology industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current Tax Provision is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Tax Provision of $0.00 Mil. The current Tax Provision is $0.00 Mil. BetterLife Pharma's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Tax Provision is $0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
29GF Score

Get the complete analysis for BETRF

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price